A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA.
Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of death by 60% in phase 3 trials. Patients who received the medication in trials lived 13.2 months, compared with those on chemotherapy, who survived 6.7 months.
The drug is approved for adults with metastatic pancreatic adenocarcinoma (PDAC). Pancreatic cancer is the third-leading cause of cancer death in the U.S. behind lung and colorectal cancers, according to the American Cancer Society.
However, the treatment comes with a steep list price of roughly $477,000 a year. What patients actually pay will depend on their insurance coverage and eligibility for financial assistance.
Double the cost of the top-selling cancer drug
In a filing with the Securities and Exchange Commission, Revolution Medicines said Rasonque has a wholesale acquisition cost, or list price before insurance discounts and rebates, of approximately $39,800 for a 30-day supply at the recommended daily dose, or about $477,000 per year.
Trade publication BioPharma Dive noted the figure is more than double the list price of Merck’s Keytruda, the top-selling cancer medication.
The list price isn’t necessarily what patients will pay, however. On the investor conference call held to announce the FDA approval on Wednesday, Revolution Medicines CFO Jack Anders said some eligible patients would be covered by Medicare Part D. Additional government discounts would lower the price by an estimated 20% to 30%.
The pharmaceutical company’s (ON)Path program says it can help patients “find the best programs and resources to help you or your loved one start on treatment as soon as possible.”
Revolution Medicines’ investor call announcing Rasonque included a presentation stating that the drug could be purchased with “as little as $0 co-pay for eligible commercially insured patients.”
A major advance in treating pancreatic cancer
Daraxonrasib is not a cure for pancreatic cancer but is a life-extending option for patients who have undergone chemotherapy with limited success.
The FDA approved the drug 35 days after accepting Revolution Medicines’ application, citing it as a “critical new option for patients facing an extraordinarily difficult and historically hard-to-treat cancer.”
The FDA noted the most common side effects as rash, diarrhea, inflammation of the mouth’s mucous membranes, nausea, fatigue, vomiting, abdominal pain, edema, decreased appetite, and hemorrhage.
Anna Berkenblit, M.D., chief scientific and medical officer for the Pancreatic Cancer Action Network (PanCAN), called the FDA’s approval “the most significant advance we have seen in the fight against pancreatic cancer, a devastating disease. In addition, an oral pill can offer a less burdensome treatment experience than standard intravenous chemotherapy.”
Some 67,000 people are expected to be diagnosed with pancreatic cancer in 2026, according to the American Cancer Society. Because there are often few or no symptoms, most patients learn they have the disease after it has spread, and treatment options are limited.
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
Reducing drug development failures with human-relevant models and AI
Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access [...]
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
